VG

Vikas Gupta

Active Director Director DIN 09014870
DIN 09014870 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Vikas Gupta

Data last updated:

Vikas Gupta is a Director at Urmed Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Urmed Pharmaceutical Private Limited reported revenue of ₹20.2 Lakh (FY 2023).

DIN 09014870
Primary Designation Director
Industry Pharma
First Appointment 30 Dec 2020
Oldest Company Age 5 yrs
Largest company Urmed Pharmaceutical Private Limited · ₹20.2 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Urmed Pharmaceutical Private Limited U51909MH2020PTC352770
Director30 Dec 20202020₹20.2 Lakh (FY 2023)Active

Board colleagues of Vikas Gupta

Directorship timeline

Open interactive timeline →
Urmed Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vikas Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Gupta

Vikas Gupta currently holds 1 directorship: Urmed Pharmaceutical Private Limited (Director, since 30 Dec 2020, revenue ₹20.2 Lakh (FY 2023)).

Vikas Gupta was first appointed on 30 Dec 2020 as Director at Urmed Pharmaceutical Private Limited.

The current boards of Vikas Gupta's companies include Dharmendra Singh Thakur (Urmed Pharmaceutical Private Limited), Vikas Patel (Urmed Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available